期刊文献+

导致α和β地中海贫血的分子病理学新机制 被引量:3

原文传递
导出
摘要 α和β地中海贫血(地贫)是被最先阐明分子基础的人类单基因病,α地贫主要是由于α珠蛋白基因大片段缺失引起,而α-地贫则主要为β-珠蛋白基因点突变所致。其经典的分子病理学机制主要聚焦在表达α-和β-珠蛋白链的结构基因缺陷上,这些经典知识尚难以圆满解释一些特殊病例中疾病发生的临床多样性和复杂性。近些年来,针对这二组疾病所展开的一些探索性研究,为我们展示了异彩纷呈的分子病理学机制新篇章。本文选择了α-和β-地贫有代表性的6种分子病理学新机制加以阐述,这些新知识不仅可用于指导地贫的临床诊治和遗传咨询,也为我们深入、系统地认识和理解人类遗传病的发生机制开启了新思路。
出处 《国际输血及血液学杂志》 CAS 2009年第6期509-514,共6页 International Journal of Blood Transfusion and Hematology
基金 国家自然科学基金委员会一广东省人民政府自然科学联合基金(U0632005)资助项目.
  • 相关文献

参考文献24

  • 1Cooley TB, Lee P. Series of cases of splenornegaly in children with anemia and peculiar bone changes. Trans Am pediatr Soc, 1925, 37: 29-30.
  • 2Rund D, Rachmilewitz E. Beta-thalassemia. N Engl J Med, 2005, 353(11):1135-1146.
  • 3Xu XM, Zhou YQ, Luo GX, et al. The prevalence and spectrum of alpha and beta thalassaemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol, 2004, 57(5):517-522.
  • 4Pauling L, Itano HA, Singer SJ, et al. Sickle-cell anemia, a molecular disease. Science, 1949, 110 : 543-548.
  • 5Weatherall DJ,Clegg JB. The Thalassaemia Syndromes. 4th edn. Oxford, Blackwell Science, 2001.
  • 6Barbonr VM, Tufarelli C, Sharpe JA, et al. alpha-thalassemia resulting from a negative chromosomal position effect. Blood, 2000, 96(3) :800-807.
  • 7Tufarelli C, Stanley JA, Garrick D, et al. Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease. Nat Genet, 2003, 34(2):157- 165.
  • 8De Gobbi M, Viprakasit V, Hughes JR, et al. A regulatory SNP causes a human genetic disease by creating a new transcriptional promoter. Science, 2006, 312(5777):1215-1217.
  • 9Li Q. A Melanesian alpha-thalassemia mutation suggests a novel mechanism for regulating gene expression. Genome Biol, 2006, 7 (10) : 238.
  • 10Viprakasit V, Kidd AM, Ayyub H, et al. De novo deletion within the telomericregion flanking the human alpha globin locus as a cause of alpha thalassaemia. Br J Haematol, 2003, 120 (5) : 867- 875.

同被引文献29

  • 1徐湘民.中国人α和β地中海贫血的分子基础及产前诊断.全国胎儿医学与产前诊断学术研讨会,2007.
  • 2Rimoin DL, Conner JM, Pyeritz RE. Emery and Rimoin' s Principles and Practice of Medical Genetics, 3rd ed. New York: Churchill Livingstone, 1996:1599-1626.
  • 3方群.产前诊断.全国围产医学新进展研讨会论文集.北京:2008.
  • 4Palmer GA,Traeger-Synodlnos J,Davies S, etal. Preoamaeies following blastocyst stage transfer in PGD cycles at risk for β-thalassaemic haemoglobinopathies. Hum Reprod ,2002,17:25-31.
  • 5Lo YM, Chiu RW. Noninvasive approaches to prenatal diagnosis of hemoglobinopathies using fetal DNA in maternal plasma. Hematol Oncol Clin North Am ,2010, 24 : 1179-1186.
  • 6Lo YM, Corbetta N, Chamberlain PF,et al. Presence of fetal DNA in maternal plasma and serum. Lancet, 1997,350:485-487.
  • 7周玉球,李文典,徐湘民.用于血红蛋白病遗传筛查的实验室诊断技术[J].国际遗传学杂志,2008,31(1):17-22. 被引量:14
  • 8陈冬,李萍,荣卡彬,梁玲,刘珍,余志衡,耿可婷,林佩萱.地中海贫血筛查实用技术的应用研究[J].中国优生与遗传杂志,2008,16(6):40-41. 被引量:18
  • 9商璇,陈万群,徐湘民.中间型β珠蛋白生成障碍性贫血的分子基础[J].实用儿科临床杂志,2009,24(3):161-164. 被引量:7
  • 10邹德学,陈卫东,丘玉辉.红细胞参数对β-地中海贫血筛查的意义[J].中国热带医学,2009,9(7):1243-1244. 被引量:3

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部